Making money in biotech stocks

Gary Vaughan from Daily Stock Picks argues that the recent market selloff presents buying opportunities, particularly in high-quality technology and semiconductor stocks such as Micron, Nvidia, and Broadcom. Strategies for navigating volatility, including buying dips, taking prof ...  Show more

Steve Cress advises investors to stay calm amid market volatility, arguing that the absence of a systemic debt crisis makes this correction a potential buying opportunity. Benefits of equal-weighted ETFs like RSP, and opportunities in Quant Strong Buy stocks such as Allstate. Res ...  Show more

In this episode, David Lebovitz, Global Strategist, Multi-Asset Solutions, is joined by Stephen Squinto, Chief Investment Officer, J.P. Morgan Life Sciences Private Capital, to discuss the alternative investment landscape, the private biotech market and areas of opportunity in 20 ...  Show more

Scott shares his thoughts on who stands to win and lose after the SEC’s approval of eleven bitcoin ETFs. He also discusses a scandal in the startup world and explains why there’s enormous opportunity in the secondary market. Finally, he breaks down his investment plans for 2024. ...  Show more

IN THIS EPISODE, YOU'LL LEARN: 10:18 - How to take positions in the market with a $5 upside and a $1 downside. 13:14 - How to make money in spin-offs. 26:45 - How to make money in risk arbitrage and merger securities. 45:57 - How call options work. BOOKS AND RESOURCES Join the ex ...  Show more